LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹581 Cr | ₹510 Cr | ₹472 Cr | ₹424 Cr | ₹386 Cr |
What is the latest Revenue of LINCOLN PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹581 Cr |
| Mar2024 | ₹510 Cr |
| Mar2023 | ₹472 Cr |
| Mar2022 | ₹424 Cr |
| Mar2021 | ₹386 Cr |
How is Revenue of LINCOLN PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹581 Cr | 13.76 | |
| Mar2024 | ₹510 Cr | 8.09 | |
| Mar2023 | ₹472 Cr | 11.30 | |
| Mar2022 | ₹424 Cr | 9.75 | |
| Mar2021 | ₹386 Cr | - | |
Compare Revenue of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹966.4 Cr | 0.6% | -4.8% | -38.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,626.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,758.0 Cr | -1.6% | -0.4% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,021.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| CIPLA | ₹122,046.0 Cr | 1% | -0.9% | -1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,086.0 Cr | 0.4% | 0.9% | -8.9% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 0.6% |
-4.8% |
-38.1% |
| SENSEX | -0.4% |
-0.6% |
8.6% |
You may also like the below Video Courses